Loading…
GH Research PLC is projected to rise to $35.59 by 2027, a +59% move from its current price of $22.36. GHRS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $21.65 | $22.37 | $23.12 | +0.06% |
| May 30 | $21.37 | $22.39 | $23.45 | +0.12% |
| May 31 | $21.17 | $22.40 | $23.71 | +0.18% |
| Jun 1 | $20.99 | $22.41 | $23.93 | +0.24% |
| Jun 2 | $20.84 | $22.43 | $24.13 | +0.30% |
| Jun 3 | $20.71 | $22.44 | $24.31 | +0.36% |
| Jun 4 | $20.59 | $22.45 | $24.48 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.59 | $22.45 | $24.48 | +0.42% |
| Week 2 | $19.95 | $22.55 | $25.49 | +0.84% |
| Week 3 | $19.49 | $22.64 | $26.31 | +1.27% |
| Week 4 | $19.12 | $22.74 | $27.04 | +1.69% |
| Week 5 | $18.81 | $22.83 | $27.71 | +2.12% |
| Week 6 | $18.55 | $22.93 | $28.35 | +2.55% |
| Week 7 | $18.31 | $23.03 | $28.95 | +2.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders.
The company was founded in 2018 and is based in Dublin, Ireland.
GH Research PLC (GHRS) is a healthcare stock with current price $22.12 and market cap $1.52B. It is ranked 2216 by market cap.
The current price is $22.12 and the market cap is $1.52B, with a market position listed as rank 2216. The technical picture points to a bullish tilt, with a sentiment labeled as BULLISH and a 14-day relative strength index of 60.
Key near-term levels show a 30-day range from $17.84 to $27.43, a support level at $16.34 and a resistance at $22.54. The stock trades with SMA50 at $18.03 and SMA200 at $15.13, and annualized volatility of 60%.
Longer-term forecast snapshots indicate a path of rising consensus prices and returns through 2050, with 2026 averaging $22.12 and reaching higher levels in subsequent years; the projected max in 2050 is $604.14.
A major floor 41.7% below — a decisive break under it would weaken the trend.
The nearest floor, 24.0% below — buyers have tended to step in here.
The nearest ceiling, 3.5% above — a clean break opens room to run.
A major ceiling 20.7% above — clearing it would confirm fresh momentum.
Key GHRS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GHRS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $22.39 | Sell | $22.37 | Sell |
| MA 10 | $22.10 | Buy | $22.09 | Buy |
| MA 20 | $21.60 | Buy | $21.37 | Buy |
| MA 50 | $18.33 | Buy | $19.35 | Buy |
| MA 100 | $16.99 | Buy | $17.59 | Buy |
| MA 200 | $15.24 | Buy | $15.84 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.25 | Neutral |
| Stoch RSI (14) | 10.14 | Buy |
| CCI (20) | 82.14 | Neutral |
| Williams %R (14) | -36.92 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | 4.39 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 63.08 | Neutral |
| TRIX (15) | 0.92 | Buy |
| Awesome (5,34) | 2.13 | Buy |
| Ultimate (7,14,28) | 58.17 | Neutral |
| Momentum (10) | 0.82 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 22.65 | Sell |
| ADX (14) | 24.38 | Buy |
| ATR (14) | 0.64 | Info |
The 30-day picture shows bullish technical conditions ahead of the near term. RSI(14) is 60, placing momentum in a balanced to slightly bullish zone.
The stock is trading above both the SMA50 ($18.03) and the SMA200 ($15.13), suggesting support from trend-following indicators. A defined support at $16.34 and resistance at $22.54 provides a bounded range for near-term movements.
The 30-day range spans from $17.84 to $27.43, highlighting recent volatility within a broad upside channel.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.03 | $22.36 | $32.35 | 0% | Neutral | |
| $27.68 | $35.59 | $48.78 | +59% | Bullish | |
| $29.39 | $39.07 | $55.82 | +75% | Bullish | |
| $31.08 | $42.49 | $62.72 | +90% | Bullish | |
| $35.47 | $49.70 | $75.43 | +122% | Bullish | |
| $35.66 | $51.14 | $79.49 | +129% | Bullish | |
| $38.86 | $56.93 | $90.43 | +155% | Bullish | |
| $48.23 | $72.10 | $116.78 | +222% | Bullish | |
| $57.33 | $87.39 | $144.10 | +291% | Bullish | |
| $62.43 | $96.94 | $162.53 | +334% | Bullish | |
| $88.65 | $149.94 | $269.47 | +571% | Bullish | |
| $143.64 | $282.68 | $561.72 | +11.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $13.03 | $22.36 | $26.36 | +0.00% |
| June 2026 | $19.69 | $23.23 | $28.12 | +3.88% |
| July 2026 | $19.82 | $23.62 | $29.05 | +1.67% |
| August 2026 | $19.14 | $22.98 | $28.62 | -2.67% |
| September 2026 | $19.30 | $23.34 | $29.35 | +1.53% |
| October 2026 | $20.31 | $24.70 | $31.35 | +5.85% |
| November 2026 | $20.51 | $25.07 | $32.07 | +1.50% |
| December 2026 | $20.42 | $25.10 | $32.35 | +0.11% |
Click any year to see its month-by-month GHRS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GHRS could reach as high as $32.35, with a base case around $22.36 and support toward $13.03 — roughly 0% from $22.36. A consolidation phase looks the most probable path here.
Expect GHRS to range from $27.68 to $48.78 through 2027. The $35.59 average target implies a +59% move from current prices. That is up +59% on the projected 2026 average. Momentum favours further upside here.
The GHRS price prediction for 2028 points to an average of $39.07 (low $29.39, high $55.82) — a potential gain of +75% on today's $22.36. Buyers look set to stay in control over this stretch.
In 2029, GHRS is projected to trade between $31.08 and $62.72, averaging $42.49 — a potential gain of +90% from today's $22.36. That is up +9% on the projected 2028 average. Momentum favours further upside here.
GH Research PLC's 2030 outlook centres on $49.70, within a $35.47 to $75.43 range. That is up +17% on the projected 2029 average. That marks a +122% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, GHRS could reach as high as $79.49, with a base case around $51.14 and support toward $35.66 — roughly +129% from $22.36. Momentum favours further upside here.
Expect GHRS to range from $38.86 to $90.43 through 2032. The $56.93 average target implies a +155% move from current prices. That is up +11% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The GHRS price prediction for 2033 points to an average of $72.10 (low $48.23, high $116.78) — a potential gain of +222% on today's $22.36. Momentum favours further upside here.
In 2034, GHRS is projected to trade between $57.33 and $144.10, averaging $87.39 — a potential gain of +291% from today's $22.36. That is up +21% on the projected 2033 average. Buyers look set to stay in control over this stretch.
GH Research PLC's 2035 outlook centres on $96.94, within a $62.43 to $162.53 range. That is up +11% on the projected 2034 average. That marks a +334% change versus current levels. Momentum favours further upside here.
By 2040, GHRS could reach as high as $269.47, with a base case around $149.94 and support toward $88.65 — roughly +571% from $22.36. Buyers look set to stay in control over this stretch.
Expect GHRS to range from $143.64 to $561.72 through 2050. The $282.68 average target implies a +11.6x move from current prices. That is up +89% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in GHRS today (≈ 44.722719 GHRS) could be worth
$12,642.26
+$11,642.26 (+1164%) by 2050 · US Dollar
Based on the average projected GHRS price of $282.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GHRSwould be worth at today's price.
$1,000 invested in GHRS on May 27, 2025 (≈ 85.470087 GHRS) would be worth
$1,911.11
+$911.11 (+91.1%) today · 1.91× · US Dollar
Based on a GHRS entry price of $11.7 vs. today's $22.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.54 | $992.01 | -0.8% |
| 1 month ago | $19.59 | $1,141.11 | +14.1% |
| 3 months ago | $15.63 | $1,430.58 | +43.1% |
| 6 months ago | $15.16 | $1,474.93 | +47.5% |
| 1 year ago | $11.7 | $1,911.11 | +91.1% |
| All time (4.9y) ago | $19.25 | $1,161.56 | +16.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GHRS forecast.
Our base-case forecast reaches $45.00 around 2030.
Implied market cap at $45.00: $3.09B
The multi-year forecast points to a bullish trajectory with steady price growth and expanding returns after 2026.
In 2026, the forecast shows an average of $22.12 with a flat ROI of 0% and a neutral sentiment, aligning with the current price level. From 2027 onward, the average price rises to $35.89 (ROI 62.3%) and climbs further in subsequent years, reaching $51.17 (ROI 131.3%) by 2030 and climbing to $304.32 (ROI 1275.8%) by 2050, all with bullish sentiment.
Notable intermediate milestones include 2033 average $76.02 and 2034 average $90.87, each with rising ROI figures, and 2040 average $158.75 (ROI 617.7%). These projections imply meaningful upside potential but remain subject to uncertainty and market conditions.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $51.17 with an ROI of 131.3% and bullish sentiment.
From 2027 onward, the forecast turns bullish with rising average prices and ROI (e.g., 2027 avg $35.89, ROI 62.3%; 2030 avg $51.17, ROI 131.3%; 2050 avg $304.32, ROI 1275.8%), though outcomes are not guaranteed and 2026 is neutral.
No. The 2050 forecast maximum is $604.14 with an average of $304.32, and no year projects as high as $2,000.
The 2040 forecast shows an average price of $158.75, a minimum of $93.95, and a maximum of $285.10, with a bullish sentiment and a ROI of 617.7%.
GH Research PLC Community Discussion
0Share your GH Research PLC price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.